Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Scott M. Gilbert is a leading urologic oncologist whose research focuses on the intersection of surgical innovation, treatment decision-making, and patient outcomes in prostate and bladder cancers. His landmark work, cited over 140 times, critically examined the rapid diffusion of advanced technologies like intensity-modulated radiotherapy (IMRT) and robotic prostatectomy among men at low risk of dying from prostate cancer, raising essential questions about the balance between technological capability and patient-centered care. Dr. Gilbert has been instrumental in evaluating the real-world implications of robotic-assisted surgery, demonstrating in population-based studies that robotic and open radical cystectomy yield comparable readmission rates, and investigating surgical control and margin status in high-risk bladder cancer cases. He contributed to the authoritative ICUD–SIU International Consultation on Bladder Cancer 2018 update on urinary diversion. His research extends to patient-reported quality of life after robotic cystectomy and the management of complications like urinary leak following partial nephrectomy. Through his work at Moffitt Cancer Center, Dr. Gilbert provides crucial evidence guiding surgical practice and technology adoption, ensuring that innovation is matched by rigorous evaluation of its impact on patient survival and recovery.